Published on Friday January 05, 2024

Smooth Drug Development December 2023 News Release

We are working on the following new projects:

  • We signed a contract for a phase III trial in patients with nasopharyngitis.

We are happy to reach the following milestones in our projects:

  • Dosing was performed in a Liraglutide trial.
  • 15 patients were randomized in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.
  • All subjects are enrolled in the observational program of multivitamins in pregnant and childbearing women. CTA for additional sites in Uzbekistan was received.
  • CTA was received in an Edoxaban trial.